HIVR4P 2016, Partnering for Prevention: Conference Summary and Highlights

• Type of Material: Article
• Authors: Barbara L. Shacklett, University of California at Davis; Cynthia Derdeyn, Emory University; Morenike Oluwatoyin Folayan, Obafemi Awolowo University; Raphael J. Landovitz, University of California Los Angeles; Colin Anthony, University of Cape Town; Anna-Janina Behrens, University of Oxford; Thomas J. Hope, Northwestern University; Elise Landais, The Scripps Research Institute; Lorna Leal, Hospital Clínic de Barcelon; Jeanne M. Marrazzo, University of Alabama Birmingham; Lynn Morris, National Institute for Communicable Disease; Nelly Mugo, Kenya Medical Research Institute; Kenneth Ngure, Jomo Kenyatta University of Agriculture & Technology; Veronica Noseda, Planned Parenthood France; Srinika Ranasinghe, Massachusetts Institute of Technology; Damien C. Tully, Massachusetts Institute of Technology; Yegor Voronin, Global HIV Vaccine Enterprise; Mitchell Warren, AVAC; Constantinos Kurt Wibmer, University of Witwatersrand; Irene Y. Xie, University of Manitoba; Gabriella Scarlatti, Global HIV Vaccine Enterprise; Bargavi Thyagarajan, Global HIV Vaccine Enterprise
• Language: English
• Date: 2017-08-01
• Publisher: Mary Ann Liebert
• Publication Version: Final Published Version
• Copyright Statement: © 2017 Barbara L. Shacklett t al.
• License: Creative Commons Attribution 4.0 International
• Final Published Version (URL): http://dx.doi.org/10.1089/aid.2017.0125
• Title of Journal or Parent Work: AIDS Research and Human Retroviruses
• ISSN: 0889-2229
• Volume: 33
• Issue: 8
• Start Page: 749
• End Page: 759
• Grant/Funding Information: HIVR4P 2016 was made possible, in part, by the support of the American people through 1 R13 AI122959-01 from the National Institute of Allergy and Infectious Diseases (NIAID), and from the United States Agency for International Development (USAID).; Significant in-kind support was provided by AVAC: Global Advocacy for HIV Prevention; Global HIV Vaccine Enterprise; Kenya Medical Research Institute; University of Alabama at Birmingham; the National Institute for Communicable Diseases; and Northwestern University.
• Keywords: Infectious Diseases; HIV prevention; Virology; MALE CIRCUMCISION; Science & Technology; R4P; UGANDA; Life Sciences & Biomedicine; TRIAL; RAKAI; MEN; microbicide; antibody; PrEP; vaccine; Immunology
• Research Categories: Health Sciences, Immunology; Health Sciences, Public Health

Abstract

HIV Research for Prevention: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P) was built on a growing consensus that effective HIV prevention requires a combination of approaches and that understanding, analyzing, and debating the cross-cutting issues that impact prevention research are all essential to combat the global HIV/AIDS epidemic. To that end, the biennial HIVR4P conference is dedicated to all biomedical HIV prevention research approaches, including HIV vaccines, microbicides, pre-exposure prophylaxis, and treatment as prevention. The HIVR4P 2016 conference was held in Chicago, Illinois (USA), on October 17-21, and included more than 700 scientific presentations and 21 satellite sessions covering the latest and most promising advances across the HIV prevention research field. The theme "Partnering for Prevention" represented the conference's commitment to breaking down silos between research disciplines as well as between researchers, program developers, care providers, advocates, communities, and funders. Delegates spanning 42 countries attended the conference. One-third of those in attendance were early career investigators, which reflects a firm commitment to emerging researchers and ultimately to the goal of developing a sustainable scientific enterprise well into the future. This article presents a concise summary of highlights from the conference. For a more detailed account, one may find full abstracts, daily summaries, and webcasts on the conference website at hivr4p.org.